Associate Professor Helmut Schaider
Associate Professor

Helmut Schaider

Email: 
Phone: 
+61 7 344 38027

Availability

Associate Professor Helmut Schaider is:
Available for supervision

Qualifications

  • Bachelor of Medicine, Karl-Franzens- Universität Graz
  • Certificate of Dermatology, Australasian College of Dermatologists

Search Professor Helmut Schaider’s works on UQ eSpace

181 works between 1991 and 2024
All (181) Journal Article (97) Conference Publication (84)

41 - 60 of 181 works

2018

Journal Article

‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi

Koh, Uyen, Janda, Monika, Aitken, Joanne F., Duffy, David L., Menzies, Scott, Sturm, Richard A., Schaider, Helmut, Betz-Stablein, Brigid, Prow, Tarl, Soyer, H. Peter and Green, Adele C. (2018). ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi. BMJ Open, 8 (9) e025857, e025857. doi: 10.1136/bmjopen-2018-025857

‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi

2018

Journal Article

Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018)

Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018). Journal of Investigative Dermatology, 138 (9), 2085-2085. doi: 10.1016/j.jid.2018.06.174

Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018)

2018

Journal Article

An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes

Joseph, Shannon R., Gaffney, Daniel, Barry, Rachael, Hu, Lingbo, Banushi, Blerida, Wells, James W., Lambie, Duncan, Strutton, Geoff, Porceddu, Sandro V., Burmeister, Bryan, Leggatt, Graham R., Schaider, Helmut, Dolcetti, Riccardo, Frazer, Ian H., Saunders, Nicholas A., Foote, Matthew, Soyer, H. Peter and Simpson, Fiona (2018). An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes. Journal of Investigative Dermatology, 139 (1), 213-223. doi: 10.1016/j.jid.2018.06.190

An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes

2018

Journal Article

Focal regression of a primary melanoma, fading lentigines, and poliosis in metastatic melanoma treated with anti-PD-1

Thomas, S, Laino, A, Sturm, R, Nufer, K, Lambie, D, Shepherd, B, Atkinson, V, Adams, L, Soyer, H P and Schaider, H (2018). Focal regression of a primary melanoma, fading lentigines, and poliosis in metastatic melanoma treated with anti-PD-1. Journal of the European Academy of Dermatology and Venereology : JEADV, 32 (5), e176-e177. doi: 10.1111/jdv.14678

Focal regression of a primary melanoma, fading lentigines, and poliosis in metastatic melanoma treated with anti-PD-1

2018

Journal Article

Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers

Hammerlindl, Heinz, Ravindran Menon, Dinoop, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens and Schaider, Helmut (2018). Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers. Clinical Cancer Research, 24 (5), 1090-1102. doi: 10.1158/1078-0432.CCR-16-2118

Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers

2018

Journal Article

Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms

Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms. Journal of Investigative Dermatology, 138 (7), 1636-1644. doi: 10.1016/j.jid.2018.02.012

Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms

2018

Conference Publication

Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis

Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Liegl-Atzwanger, Bernadette, Wodlej, Christina, Grissenberger, Sarah, Preishuber-Pfluegl, Julia, Lohner, Karl and Zweytick, Dagmar (2018). Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis. 35th European Peptide Symposium, Dublin, Ireland, 26th-31st August, 2018 . Oxford, United Kingdom: John Wiley & Sons .

Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis

2018

Conference Publication

Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma

Menon, D. Ravindran, Hammerlindl, H., Emran, A., Torrano, J., Hammerlindl, S., Zhang, G., Krause, L., Somasundaram, R., Sturm, R., Haass, N. K., Flaherty, K., Herlyn, M. and Schaider, H. (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma. International Investigative Dermatology (IID) Meeting, Orlando, Fl, United States, 16-19 May 2018. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2018.03.1252

Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma

2018

Conference Publication

The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells

Uranowska, K., Kalic, T., Karapandza, K., Ellinger, I., Breiteneder, H., Schaider, H. and Hafner, C. (2018). The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells. 45th Annual Meeting of the Arbeitsgemeinscha-Dermatologische-Forschung (ADF), Zurich Switzerland, Mar 07-10, 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells

2018

Conference Publication

Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma

Schukoff, T., Winkler, S., Unterluggauer, J. J., Fechter, K., Greinix, H., Beham-Schmid, C., Schaider, H., Deutsch, A., Prochazka, K. and Neumeister, P. (2018). Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma. Deutscher Krebskongress, Berlin, Germany, 21-24 February 2018. Basel, Switzerland: S. Karger.

Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma

2018

Journal Article

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation

Tan, J. M., Tom, L. N., Jagirdar, K., Lambie, D., Schaider, H., Sturm, R. A., Soyer, H. P. and Stark, M. S. (2018). The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation. British Journal of Dermatology, 178 (1), 191-197. doi: 10.1111/bjd.15809

The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation

2018

Conference Publication

Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma

Emran, A., Marzese, D. M., Menon, D. R., Stark, M., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Hammerlindl, S., Gupta, D., Mills, G. B., Lu, Y., Flaherty, K., Sturm, R., Hoon, D. S. B., Gabrielli, B., Herlyn, M. and Schaider, H. (2018). Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia , 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.16_12815

Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma

2018

Conference Publication

Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma

Emran, A., Chowdhury, B. R., Hammerlindl, H., Ahmed, F., Haass, N. K., Schuehly, W. and Schaider, H. (2018). Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Hoboken, NJ, United States: Wiley.

Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma

2018

Conference Publication

Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanoma

Menon, Dinoop Ravindran, Hammerlindl, Heinz, Al Emran, Abdullah, Torrano, Joachim, Hammerlindl, Sabrina, Zhang, Gao, Somasundaram, Rajasekharan, Sturm, Richard A., Haass, Nikolas K., Flaherty, Keith, Herlyn, Meenhard and Schaider, Helmut (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, IL United States, 14-18 April 2018. Philadelphia, PA United States: American Association of Cancer Research. doi: 10.1158/1538-7445.AM2018-5833

Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanoma

2018

Conference Publication

Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms

Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, Illinois, 14-18 April 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2018-5376

Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms

2017

Journal Article

Distinct histone modifications denote early stress-induced drug tolerance in cancer

Emran, Abdullah Al, Marzese, Diego M., Menon, Dinoop Ravindran, Stark, Mitchell S., Torrano, Joachim, Hammerlindl, Heinz, Zhang, Gao, Brafford, Patricia, Salomon, Matthew P., Nelson, Nellie, Hammerlindl, Sabrina, Gupta, Deepesh, Mills, Gordon B., Lu, Yiling, Sturm, Richard A., Flaherty, Keith, Hoon, Dave S. B., Gabrielli, Brian, Herlyn, Meenhard and Schaider, Helmut (2017). Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget, 9 (9), 8206-8222. doi: 10.18632/oncotarget.23654

Distinct histone modifications denote early stress-induced drug tolerance in cancer

2017

Journal Article

Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA

Aberer, Elisabeth, Surtov-Pudar, Milana, Wilfinger, Daniel, Deutsch, Alexander, Leitinger, Gerd and Schaider, Helmut (2017). Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Archives of Dermatological Research, 310 (2), 117-126. doi: 10.1007/s00403-017-1797-1

Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA

2017

Journal Article

Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance

Hammerlindl, Heinz and Schaider, Helmut (2017). Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance. Journal of Cell Communication and Signaling, 12 (1), 133-141. doi: 10.1007/s12079-017-0435-1

Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance

2017

Journal Article

The evolving universe of BRAF mutations in melanoma

Schaider, H and Sturm, R A (2017). The evolving universe of BRAF mutations in melanoma. The British Journal of Dermatology, 177 (4), 893-893. doi: 10.1111/bjd.15829

The evolving universe of BRAF mutations in melanoma

2017

Journal Article

Classifying dermoscopic patterns of naevi in a case-control study of melanoma

McWhirter, Seamus R, Duffy, David L, Lee, Katie J, Wimberley, Glen, McClenahan, Philip, Ling, Natalie, Ardigo, Marco, Schaider, Helmut, Soyer, H Peter and Sturm, Richard A (2017). Classifying dermoscopic patterns of naevi in a case-control study of melanoma. PloS One, 12 (10) e0186647, 1-10. doi: 10.1371/journal.pone.0186647

Classifying dermoscopic patterns of naevi in a case-control study of melanoma

Current funding

  • 2024 - 2026
    Preventing the cancer-promoting effects of tacrolimus on UV-treated keratinocytes
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2024 - 2029
    Compound Discovery for Cancer Recurrence research
    Research Donation Generic
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2027
    The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2019 - 2022
    O-linked-N-acetylglucosamine transferase and ten-eleven translocation 1 facilitate therapy induced cellular reprogramming leading to acquired drug resistance in cancer
    Cancer Council Queensland
    Open grant
  • 2018 - 2022
    Improving outcomes for patients with melanoma brain metastases using novel personalised and response-adapted treatment strategies (PARF Translation Research Innovation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018
    Targeted and personalised early detection of melanoma using a 3D teledermatology network
    PA Research Foundation
    Open grant
  • 2017 - 2018
    Cutting-edge Imaging System for the Early Diagnosis of Face and Scalp Skin Cancer
    The Honda Foundation
    Open grant
  • 2017 - 2019
    Melanoma environment and heterogeneity in therapy sensitivity and resistance - Schaider
    Meehan Bequest
    Open grant
  • 2016 - 2019
    The role of chondroitin sulfate proteoglycan 4 (CSPG4) in the induction of multidruQ tolerance in melanoma cells (NO Forschung und Bildung funding led by Karl Landsteiner Uni for Med Sci)
    Karl Landsteiner University of Health Sciences
    Open grant
  • 2016
    Epigenetic remodelling driving acquired permanent drug resistance in melanoma cells
    PA Research Foundation
    Open grant
  • 2015 - 2021
    Centre of Research Excellence for the Study of Naevi
    NHMRC Centres of Research Excellence
    Open grant
  • 2015 - 2017
    Topical application of ORIL007 in two different mouse models
    Oncology Research International Ltd
    Open grant
  • 2015 - 2018
    Defining the role of Microphthalmia-associated Transcription Factor (MITF) in melanoma heterogeneity by real-time cell cycle imaging
    NHMRC Project Grant
    Open grant
  • 2015
    Next-generation cell analysis: Automated high-throughput 3D microscope and multimode microplate reader
    NHMRC Equipment Grant
    Open grant
  • 2014 - 2016
    Genetic polymorphisms associated with clinical and dermoscopic naevus signature patterns
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Targeted expression of US28/GNA12/13 fusion proteins for cancer therapy
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant

Availability

Associate Professor Helmut Schaider is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Associate Professor Helmut Schaider's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au